IL10 and myeloid sarcoma: The study of the area under the curve (AUC) showed that the inflammatory markers could not identify the subjects who have MS, except for the IL-10/TNF-α ratio for the NCEP ATP-III method, which showed a sensitivity of 72.2% and specificity of 63.4%.